- Home
- SGMT vs SPCE Comparison
SGMT vs SPCE Comparison
Compare SGMT & SPCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SGMT
- SPCE
- Stock Information
- Founded
- SGMT 2006
- SPCE 2017
- Country
- SGMT United States
- SPCE United States
- Employees
- SGMT N/A
- SPCE N/A
- Industry
- SGMT
- SPCE Transportation Services
- Sector
- SGMT
- SPCE Consumer Discretionary
- Exchange
- SGMT Nasdaq
- SPCE Nasdaq
- Market Cap
- SGMT 131.4M
- SPCE 148.0M
- IPO Year
- SGMT 2023
- SPCE N/A
- Fundamental
- Price
- SGMT $8.72
- SPCE $2.99
- Analyst Decision
- SGMT Strong Buy
- SPCE Hold
- Analyst Count
- SGMT 6
- SPCE 4
- Target Price
- SGMT $23.17
- SPCE $13.06
- AVG Volume (30 Days)
- SGMT 3.2M
- SPCE 4.3M
- Earning Date
- SGMT 08-13-2025
- SPCE 08-06-2025
- Dividend Yield
- SGMT N/A
- SPCE N/A
- EPS Growth
- SGMT N/A
- SPCE N/A
- EPS
- SGMT N/A
- SPCE N/A
- Revenue
- SGMT N/A
- SPCE $5,512,000.00
- Revenue This Year
- SGMT N/A
- SPCE N/A
- Revenue Next Year
- SGMT N/A
- SPCE $4,110.27
- P/E Ratio
- SGMT N/A
- SPCE N/A
- Revenue Growth
- SGMT N/A
- SPCE N/A
- 52 Week Low
- SGMT $1.73
- SPCE $2.18
- 52 Week High
- SGMT $9.60
- SPCE $10.00
- Technical
- Relative Strength Index (RSI)
- SGMT 74.80
- SPCE 43.57
- Support Level
- SGMT $6.56
- SPCE $2.90
- Resistance Level
- SGMT $9.60
- SPCE $3.14
- Average True Range (ATR)
- SGMT 1.13
- SPCE 0.23
- MACD
- SGMT 0.29
- SPCE -0.05
- Stochastic Oscillator
- SGMT 85.71
- SPCE 9.71
About SGMT Sagimet Biosciences Inc. Series A
Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company dedicated to developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors aimed at treating diseases that arise from dysfunctional lipid metabolism pathways. The company's drug candidate, denifanstat, is an oral, once-daily pill that serves as a selective FASN inhibitor under development for treating nonalcoholic steatohepatitis (NASH). The company functions as a single business segment, focusing on the development and commercialization of therapeutics for MASH and other diseases where FASN plays a pathogenic role.
About SPCE Virgin Galactic Holdings Inc.
Virgin Galactic Holdings Inc is a United States-based vertically integrated aerospace company pioneering human spaceflight for private individuals & researchers, and it also manufactures advanced air and space vehicles. Using technologies, the company is developing a spaceflight system designed to offer its customers a multi-day, and transformative experience. This culminates in a spaceflight that includes views of Earth from space and several minutes of weightlessness that will launch from Spaceport America, New Mexico.